• SPX
  • 5969.34
  • 0.35 %
  • 20.6299
  • DJI
  • 44296.51
  • 0.97 %
  • 426.1602
  • N225
  • 38283.85
  • 0.68 %
  • 257.6797
  • FTSE
  • 8262.08
  • 1.38 %
  • 112.8101
  • IXIC
  • 19003.65
  • 0.16 %
  • 31.2305
Notable Labs, Ltd. (NTBL) Stock Price, News & Analysis

Notable Labs, Ltd. (NTBL) Stock Price, News & Analysis

Currency in USD Disclaimer

NA

NA

NA

Day's range
$0.25
Day's range
$0.3
50-day range
$0.0121
Day's range
$0.6658
  • Country: US
  • ISIN: IL0012002452
52 wk range
$0.1
Day's range
$4.24
  • CEO: Dr. Thomas A. Bock M.B.A., M.D.
  • Website: Visit Site
Notice: This company has been marked as potentially delisted and may not be actively trading.


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score -15.32
  • Piotroski Score 1.00
  • Grade Buy
  • Symbol (NTBL)
  • Company Notable Labs, Ltd.
  • Price $0.25
  • Changes Percentage (0%)
  • Change -$0
  • Day Low $0.25
  • Day High $0.30
  • Year High $4.24

Notable Labs, Ltd., a clinical-stage platform therapeutics company, engages in developing predictive precision medicines for patients with cancer. The company, through its proprietary Predictive Precision Medicines Platform (PPMP), bio-simulates a cancer treatment and predicts, whether or not the patient is likely to respond to that specific therapeutic. Its PPMP is designed to identify and select clinically responsive patients prior to their treatment and thus fast-track clinical development in this patient population. The company's pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor for acute myeloid leukemia (AML), pediatric leukemia, and myelodysplastic syndromes indications; and Fosciclopirox, a pro-drug of ciclopirox for AML. Notable Labs, Ltd. is headquartered in Foster City, California.

  • Last Earnings
  • Ex-Dividend for 5/16 Dividend
  • Dividend Payable
  • Today N/A
  • Next Earnings (Estimated) 11/11/2024
  • Fiscal Year End N/A

  • Average Stock Price Target $0.00
  • High Stock Price Target $0.00
  • Low Stock Price Target $0.00
  • Potential Upside/Downside N/A
  • Consensus Rating Sell
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) -$0.97
  • Trailing P/E Ratio -0.88
  • Forward P/E Ratio -0.88
  • P/E Growth -0.88
  • Net Income $-11,264,000

Income Statement

Quarterly

Annual

Latest News of NTBL

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

  • 'The Great Gatsby' Inspires a Montblanc Pen Collection

    Montblanc's Great Characters Editions now feature a fictional character, Jay Gatsby from "The Great Gatsby". This unique collection sparks conversation about human values, wealth, and happiness. The n...

    By The New York Times | 1 week ago
Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

Notable Labs, Ltd. Frequently Asked Questions

  • What were the earnings of NTBL in the last quarter?

    In the last quarter Notable Labs, Ltd. earnings were on Tuesday, November, 12th. The Notable Labs, Ltd. maker reported -$0.48 EPS for the quarter, beating analysts' consensus estimates of -$0.68 by $0.20.

  • What is the Notable Labs, Ltd. stock price today?

    Today's price of Notable Labs, Ltd. is $0.25 — it has decreased by 0% in the past 24 hours. Watch Notable Labs, Ltd. stock price performance more closely on the chart.

  • Does Notable Labs, Ltd. release reports?

    Yes, you can track Notable Labs, Ltd.'s financials in yearly and quarterly reports directly on Stocks.News.

  • What is the Notable Labs, Ltd. stock forecast?

    Watch the Notable Labs, Ltd. chart and read a more detailed Notable Labs, Ltd. stock forecast to see what analysts suggest you do with its shares.

  • What is Notable Labs, Ltd. stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NASDAQ, exchange stock trades by Notable Labs, Ltd. stock ticker.

  • How to buy Notable Labs, Ltd. stocks?

    Like other stocks, NTBL shares are sold on stock exchanges such as NASDAQ. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is Notable Labs, Ltd.'s EBITDA?

    Notable Labs, Ltd. measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in Notable Labs, Ltd.’s financial statements.

  • What is the Notable Labs, Ltd.'s net income ratio for the financial year 2023?

    The net income ratio for the financial year 2023 is -36.335483871, which equates to approximately -3,633.55%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in Notable Labs, Ltd. stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including Notable Labs, Ltd.'s financials relevant news, and technical analysis. Notable Labs, Ltd.'s technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for Notable Labs, Ltd. stock currently indicates a “sell” signal. For more insights, review Notable Labs, Ltd.’s technical analysis.

  • A revenue figure for Notable Labs, Ltd. for its last quarter?

    Notable Labs, Ltd. published it's last quarterly revenues at $2,000.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.